Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2301studies shown
Showing 637-648 of 2,301
Drug study icon
CompletedNCT05454410

MIJ821 for treatment-resistant depression

This study is completed in the United States, in Japan, in Poland, .... It is testing MIJ821 for treatment-resistant depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, Japan, Poland, ...
Sponsor
Novartis Pharmaceuticals
Condition
Depression
Device study icon
Active Not RecruitingNCT06236711

Transcranial Direct Current Stimulation (tDCS) as an Adjunctive Treatment for Treatment Resistant Depression (TRD)

This study is looking at whether tDCS can help people with Treatment Resistant Depression. Participants take part in tDCS and complete follow-up assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.Over 18 Years
Countries
United States
Sponsor
Mayo Clinic
Condition
Depression
Drug study icon
CompletedNCT01627782

Ketamine for treatment-resistant depression

This study is completed in the United States. It is testing ketamine for treatment-resistant depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 64 Years
Countries
United States
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Device study icon
Active Not RecruitingNCT05849402

Accelerated Intermittent Theta-Burst Stimulation (aiTBS) in Treatment-Resistant Depression of Bipolarity type II

This study is looking at care and outcomes for people with Bipolarity II, Most Recent Episode Major Depressive, Current Depressive Episode, or Treatment Resistant Depression. Some participants may receive Sham aiTBS instead of the study treatment, and direct benefit is not guaranteed.

In United States
Why is this study shown?

This study is directly about Depression.

Depression, BipolarityDeviceFrom 18 Years to 80 Years
Countries
United States
Sponsor
Stanford University
Condition
Depression, Bipolarity
Behavioral study icon
Active Not RecruitingNCT01798407

DBS of the Lateral Habenula in Treatment-Resistant Depression

This study is comparing Activa Tremor Control Sys (DBS Implant) with Activa Tremor Control Sys (DBS Implant) for people with Treatment Resistant depression. Participants receive Activa Tremor Control Sys (DBS Implant) or Activa Tremor Control Sys (DBS Implant) and complete study visits and assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 21 Years to 70 Years
Countries
United States
Sponsor
Wayne Goodman MD
Condition
Depression
Behavioral study icon
CompletedNCT00367003

Deep Brain Stimulation for Treatment Resistant Depression

This study is looking at whether a digital support tool can help people with depression. Participants receive a study treatment and complete follow-up visits and assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 70 Years
Countries
United States
Sponsor
Emory University
Condition
Depression
Device study icon
TerminatedNCT03360942

Long Term Follow-up of Deep Brain Stimulation for Treatment-Resistant Depression

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can better prevent setbacks and support longer-term stability.

Remote / online
Why is this study shown?

This study is directly about Depression.

Depression, BipolarityDeviceFrom 18 Years to 70 Years
Countries
United States
Sponsor
Dartmouth-Hitchcock Medical Center
Condition
Depression, Bipolarity
Behavioral study icon
TerminatedNCT06682299

Maintenance TMS in Treatment Resistant Depression

This study is looking at whether Transmagnetic Stimulation can help people with Treatment Resistant Depression. Participants receive a study treatment and complete follow-up visits and assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
Austin Messner
Condition
Depression
Drug study icon
WithdrawnNCT05710887

N2O for Acute Suicide prevention and Depression in the ED

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In United States
Why is this study shown?

This study is directly about Depression.

Depression, SuicidalityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Chicago
Condition
Depression, Suicidality
Behavioral study icon
CompletedNCT06357832

New Investigational Stimulation Protocol for Treatment of Major Depression Disorder (MDD)

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

Remote / online
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 22 Years to 68 Years
Countries
United States, India, Israel
Sponsor
Brainsway
Condition
Depression
Drug study icon
CompletedNCT06836063

Ropanicant for Depression

This study is completed in the United States. It is testing ropanicant for Depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Suven Life Sciences Limited
Condition
Depression
Drug study icon
CompletedNCT04979910

Targeting IL-17A for Treatment-Resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Icahn School of Medicine at Mount Sinai
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.